Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-01-24 @ 9:02 PM
Study NCT ID:
NCT05411133
Status:
RECRUITING
Last Update Posted:
2025-09-04
First Post:
2022-05-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Sponsor:
Arbele Pty Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None